高雄榮民總醫院婦女醫學部生殖醫學中心

	李佳榮 博士  Chia-Jung Li, Ph.D.   Office: +886-7-342-2121 #71562 Lab: +886-7-342-2121 #74048
Research Fellow 研究員	Email: cjli@vghks.gov.tw

Education and Experience / 學經歷

• 2024 – Research Fellow, Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Taiwan. / 高雄榮民總醫院 婦女醫學部 研究員
• 2020 – ssociate Professor, Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Taiwan / 國立中山大學生技醫藥研究所 合聘副教授
• 2019 – 2024 Present Associate Research Fellow / Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Taiwan. / 高雄榮總婦女醫學部  副研究員
• 2020 – Assistant Professor / 教育部頒定助理教授
• 2017 – 2019 Researcher & Team Leader / Research Assistance Center, Show Chwan Memorial Hospital, Taiwan. / 秀傳紀念醫院醫研部  研究員兼組長
• 2017 – 2019 Executive editor, Show Chwan Medical Journal. / 秀傳醫學雜誌  執行編輯
• 2015 – 2017 Postdoctoral Research Fellow, Ministry of Science and Technology (MOST), National Cheng Kung University, Institute of Clinical Medicine, Taiwan. / 國立成功大學臨床醫學研究所  博士後研究員
• 2015 Ph.D., Institute of Medical Sciences, Tzu Chi University, Taiwan. / 慈濟大學  醫學科學研究所 博士

Editor & Reviewer / 期刊編輯與審查

Editor Board / 主編:

• International Journal of Reproductive Medicine (2022-)

• Cancer Medicine (2022-)

• Biology (2023-)

• Biomedical Reports (2024-)

• Discover Oncology (2024-)

Lead Guest Editor / 客座主編:

• Biomedicines (IF: 4.757; 2022)
  -Special Issue: Mitochondrial Dysfunction and Oxidative Stress in Aging and Disease 2.0

• Frontiers in Bioscience-Landmark (IF: 3.115; 2022)
  -Special Issue: Multi-Omics Biomarker Signatures in Precision Cancer Medicine

• Disease Markers (IF: 3.434; 2022)
  -Special Issue: The Role of Epithelial-Mesenchymal Transition (EMT)-Related Biomarkers in Disease

• Technology in Cancer Research & Treatment (IF: 3.399; 2022)
  -Special Issue: Novel Biomarkers, Molecular Diagnostics and Targeted Therapies of Cancer

• Frontiers in Pharmacology (IF: 4.4; 2022)
  -Special Issue: Advances on Epigenetics Pharmacological Research for Chest-related Disease

• Journal of Personalized Medicine (IF: 4.945; 2021)
  -Special Issue: Advances in the Research of Endocrine and Metabolic Disorders in the Human Reproductive System

• Journal of Visualized Experiments (IF: 1.355; 2021)
  -Special Issue: Methods Collections-Current research in mitochondrial medicine

• Journal of Personalized Medicine (IF: 4.945; 2021)
  -Special Issue: Precision Medicine in Breast Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes

• Biomedicines (IF: 6.081; 2021)
  -Special Issue: Mitochondrial Dysfunction and Oxidative Stress in Aging and Disease

• Oxidative Medicine and Cellular Longevity (IF: 5.076; 2020)
  -Special Issue: Infertility and Assisted Reproduction: the Impact of Oxidative Stress

• Cancer Control (IF: 3.103; 2020)
  -Special Issue: Molecular Bases of Carcinogenesis

• Biomolecules (IF: 4.694; 2019)
  -Special Issue: Oxidative Stress and Mitochondrial Dysfunction in Human Diseases: Pathophysiology, Predictive Biomarkers, Therapeutic

• Journal of Oncology (IF: 4.593; 2018)
  -Special Issue: Diagnostic, Prognostic and Predictive Biomarkers in Breast Cancer

Awards & Distinctions / 獎項 & 榮譽

1. 2023/12 受邀為麻醉醫學會聯合討論會講者
2. 2023/12 獲選乳癌防治基金會優秀論文獎
3. 2023/11 受邀至高雄師範大學生物科技系演講
4. 2023/10 受邀至高雄長庚紀念醫院震波醫學與組織再造研究中心演講
5. 2023/10 受邀至高雄醫學大學研發處演講
6. 2023/12 獲選台北國際乳癌研討會優秀論文獎  
7. 2023/09 受邀至四榮暨三總乳癌治療共識會議演講
8. 2022/11 受邀至高雄長庚紀念醫院粒線體醫學研究中心演講  
9. 2022/07 獲證智財局發明專利 
10. 2022/06 獲退輔會頒發研究計畫報告特優獎  
11. 2022/04 國際期刊Cancer Biology & Medicine (IF: 5.347)選為2020年優秀審委獎 
12. 2021/04 受邀為國際亞太生殖醫學(ASPIRE)研討會大會講者
13. 2021/11 獲選台北國際乳癌研討會(TIBCS)優秀論文獎  
14. 2021/07 獲Journal of Clinical Medicine (IF: 4.421)國際期刊選為2021年度封面故事獎  
15. 2020/11 獲選乳癌防治基金會優秀論文獎
16. 2020/10 獲選粒線體研討會優秀論文獎
17. 2020/10 獲選台北國際乳癌研討會(TIBCS)優秀論文獎
18. 2020/08 獲選生殖醫學年會(TSRM)優秀口頭論文獎
19. 2019/11 獲選乳癌防治基金會優秀論文獎
20. 2019/09 論文獲國際期刊Theranostics (IF: 12.4)選為該期封面故事
21. 2019/08 獲選生殖醫學年會(TSRM)口頭論文競賽第一名
22. 2019 - 受邀至台灣醫事檢驗年會演講
23. 2019 - 論文獲國際期刊Journal of Clinical Medicine (IF: 5.688)選為該期封面故事(Vol:8, Issue:4)
24. 2019 - 受邀至台南市立醫院全院性演講
25. 2018 - 獲選粒線體研討會(TSMRM)傑出論文獎
26. 2018 - 論文獲國際期刊Journal of Clinical Medicine (IF: 5.688)選為該期封面故事(Vol:7, Issue:8)
27. 2018 - 受邀至台中慈濟醫院醫研部演講
28. 2017 - 受邀為粒線體醫學研討會(TSMRM)大會講者
29. 2017 -受邀至台南市立醫院全院性演講
30. 2016 - Travel Award (Tokyo, Japan). 獲科技部補助專家學者出席國際會議
31. 2016 - Travel Award (Tokyo, Japan). 獲細胞分子生物學會補助專家學者出席國際會議
32. 2016 - 受邀為中國南京第三屆生物醫學工程與製藥科學國際會議 (ICBEPS)大會講者
33. 2014 - 獲選亞洲粒線體研討會(ASMRM)傑出論文獎
34. 2014 - 獲選慈濟學術會議傑出論文獎
35. 2012 - 獲選粒線體研討會(TSMRM)傑出論文獎
36. 2012 - Travel Award (Boston, USA). The Chinese Society of Cell and Molecular Biology, Taiwan. 獲細胞分子生物學會補助專家學者出席國際會議
37. 2011 - Travel Award. 1^st Workshop on Systems Biology of Tumor Dormancy, MA. USA. / 獲美國會議補助專家學者出席國際會議

List of Publications / 論文著述

2024

1. Tsui KH, Hsiao HJ, Lin LT, Tsang YL, Kuo CH, Chang R, Wen ZH, Li CJ*. The Cross-Communication of Cuproptosis and Regulated Cell Death in Human. Int J Biol Sci. 20:218. IF: 9.2. 2024.
2. Detweiler P, Wu P, Li CJ, Yong SB. Comment on “Estrogen deficiency induces bone loss through the gut microbiota”. Pharmacol Res. 107132. IF: 9.3. 2024.
3. Huang XZ, Yii CY, Yong SB, Li CJ*. peu-MIR2916-p3-enriched garlic exosomes ameliorate murine colitis by reshaping gut microbiota, especially by boosting the anti-colitic Bacteroides thetaiotaomicron – correspondence. Pharmacol Res. 107131. IF: 9.3. 2024.
4. Chang R, Tsui KH, Tzeng YD, Hsiao JH, Tsang YL, Kuo CH, Li CJ*. Spatial and Single-Cell Analyses Reveal Correlation between Histone H2A Dioxygenase Gene Expression and Tumor-Associated Macrophages in Gastric Cancer. Cancer Cell International. 24:57. IF: 5.8. 2024.
5. Lee HP, Li CJ, Lee CC. EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling. Head Neck. Accepted. IF: 2.9. 2024.
6. Hsu LC, Li CJ, Lin LT, Pan LF, Wen ZH, Sheu JC, Tsui KH. Multi-omics reveals the role of osteopontin/SPP1 in regulating ovarian aging. J Pers Med. 14:78. IF: 3.4. 2024.
7. Chen CJ, Kao HY, Huang CH, Li CJ, Hung CH, Yong SB. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults. Ital J Pediatr. 50:18. IF: 3.6. 2024. 
8. Chou YY, Li CJ, Kao CL, Kuo CE, Tzeng YD, Hsiao JH. Suppression of CDC42 Potential in Breast Cancer Tumor Microenvironment by Tumor Necrosis Factor Inhibitors. Int J Rheum Dis.  27:e14934. IF: 2.5. 2024. 
9. Chen PH, Wu MY, Liao WT, Yong SB, Li CJ*, Jou IM. Targeted antibodies and tumor microenvironment dynamics in dermatomyositis Shared therapeutic approaches. Int J Rheum Dis.  27:e15045. IF: 2.5. 2024. 
10. Chen PH, Yong SB, Liao WT, Wu MY, Li CJ*, Jou IM. Targeting Osteoblast-Specific Transcription Factor: A Common Approach for Ankylosing Spondylitis and the Tumor Microenvironment. Int J Rheum Dis.  Accepted. IF: 2.5. 2024. 

2023

16. Tzeng YD, Hsiao JH, Chu PY, Tseng LM, Hou MF, Tsang YL, Shao AN, Sheu JC, Li CJ*.  The Role of LSM1 in Breast Cancer: Shaping Metabolism and Tumor-Associated Macrophage Infiltration. Pharmacol Res. 198:107008. IF: 9.3. 2023.
17. Tzeng YD, Hsiao JU, Tseng LM, Hou MF, Li CJ*. Breast Cancer Organoids Derived from Patients: A Platform for Tailored Drug Screening. Biochem Pharmacol. 12:115803. IF: 5.8. 2023.
18. Wen CY, Hsiao JH, Tzeng YD, Chang R, Tsang YL, Kuo CH, Li CJ*. Single-cell landscape analysis reveals macrophage infiltration and glycolytic metabolism in kidney renal clear cell carcinoma. Aging. 15:11298. IF: 5.2. 2023.
19. Tsui KH, Li CJ. Mitoquinone shifts energy metabolism to reduce ROS-induced oxeiptosis in female granulosa cells and mouse oocytes. Aging. 15:246. IF: 5.2. 2023.
20. Chang WS, Lin PH, Li CJ, Chen CU, Chen YC, Lin LT, Tsui KH. Additional single dose GnRH agonist during luteal phase support may improve live birth rate in GnRHa-HRT frozen-thawed embryo transfer cycle: a retrospective cohort study. BMC Pregnancy Childbirth. 23: 174. IF: 3.1. 2023. 
21. Su WP, Li CJ, Lin LT, Lin PH, Wen ZH, Sheu JC, Tsui KH. Boosting mitochondrial function and metabolism in aging female germ cells with dual ROCK/ROS inhibition. Biomed Pharmacother. 163:114888. IF: 7.5. 2023.
22. Lin PH, Su WP, Li CJ, Lin LT, Sheu JC, Wen ZH, Cheng JT, Tsui KH. Investigating the Role of Ferroptosis-Related Genes in Ovarian Aging and the Potential for Nutritional Intervention. Nutrients. 15:2461. IF: 5.9. 2023.
23. Shih PY, Li CJ*, Yong SB. Emerging Trends in Clinical Research on Janus Kinase Inhibitors for Atopic Dermatitis Treatment. Int Immunopharmacol. 124:111029. IF: 5.6. 2023.
24. Yong SB, GauSY, Li CJ, Tseng CW, Wang SI, Wei CC. Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid. Front Pharmacol. 14:1204297.  IF: 5.6. 2023.
25. Lin PH, Li CJ, Lin LT, Su WP, Sheu JC, Wen ZH, Cheng JT, Tsui KH. Unraveling the Clinical Relevance of Ferroptosis-Related Genes in Human Ovarian Aging. Reprod Sci. 30:3529. IF: 2.9. 2023.
26. Chou MC, Lee WK, Yeh WB, Yong SB, Li CJ, Chang R. CAR T-cells: New therapeutic opportunities in autoimmune diseases? Int J Rheum Dis. 26:1427.  IF: 2.5. 2023.
27. Hsiao JH, Chou YY, Li CJ*, Tzeng YD. Learning from Osteoporosis: TCF4 as a Promising Companion Biomarker for Breast Cancer. Int J Rheum Dis. 26:1220. IF: 2.5. 2023. 
28. Chou MC, Lee WK, Chen PH, Pan LF, Yong SB, Li CJ*. Discovery of a Shared Therapeutic Target in Granulomatosis with Polyangiitis and Gastric Tumor Microenvironment. Int J Rheum Dis. 26:1217. IF: 2.5. 2023. 
29. Chen PH, Yeh WB, Kao CL, Kuo CE, Li CJ*, Pan LF. Identification of a Common Therapeutic Objective in both rheumatoid arthritis and the microenvironment of gastric tumors. Int J Rheum Dis. 27:e14932. IF: 2.5. 2023. 
30. Huang CW, Yeh WB, Shao AN, Li CJ*, Pan LF. Calprotectin: A Shared Biomarker in Psoriatic Arthritis and Renal Cancer.  Int J Rheum Dis. 26:1427. IF: 2.5. 2023. 

2022

19. Li CJ, Lin LT, Tsai HW, Wen ZH, Tsui KH. Phosphoglycerate mutase family member 5 maintains oocyte quality via mitochondrial dynamic rearrangement during aging. Aging cell. 21:e13546. IF: 11.005. 2022.
20. Li CJ, Chang CH, Tsang YL, Fang SH, Chen SN, Chiang AJ. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma. Int Immunopharmacol. 112:109273. IF: 5.714. 2022.
21. Tzeng YT, Tsui KH, Tseng LM, Hou MF, Chu PY, Sheu JJ, Li CJ*. Integrated analysis of pivotal biomarker, immune cell infiltration and therapeutic drugs for LSM1-mutated in breast cancer. J Cell Mol Med. 26:4007. IF: 5.295. 2022. 
22. Chu PY, Tzeng YD, Tsui KH, Chu CY, Li CJ*. Downregulation of ATP binding cassette subfamily A member 10 acts as a prognostic factor associated with immune infiltration in breast cancer.  Aging. 14:2252. IF: 5.955. 2022.
23. Wen CY, Tsui KH, Chang CH, Chiu YH, Lin SC, Chu CY, Li CJ*. Integrative multiomics evaluation of IDH1 metabolic enzyme as a candidate oncogene that is correlated with poor prognosis and immune infiltration in prostate adenocarcinoma. J Oncol. 2021:9854799. IF: 4.501. 2022.
24. Tsang YL, Kao CL, Lin SC, Li CJ*. Mitochondrial Dysfunction and Oxidative stress in Aging and Disease. Biomedicines. 10:2872. IF: 4.757. 2022. 
25. Liao WT, Chu PY, Su CC, Wu CC, Li CJ*. Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer.  Pathol Res Pract. 240:154215. IF: 3.309. 2022.
26. Yeh WB, Lee WK, Chou MC, Yong SB, Li CJ*. Survivin promotes rheumatoid arthritis fibroblast-like synoviocyte cell proliferation, and the expression of angiogenesis-related proteins by activating the NOTCH pathway: Correspondence. Int J Rheum Dis. 26:984. IF: 2.558. 2022. 
27. Kao SS, Li CJ, Wei CC, Lin CL, Chang R, Hung YM. Human papillomavirus infection is associated with decreased risk of hepatocellular carcinoma in chronic hepatitis C patients: Taiwan nationwide matched cohort study. Cancers. 14:1289. IF: 6.575. 2022. 
28. Chang CY, Chiang AJ, Lai MT, Yan MJ, Tseng CC, Lo LC, Wan L, Li CJ, Tsui KH, Chen CM, Hwang T, Tsai FJ, Sheu JJ. A more diverse cervical microbiome associates with better clinical outcomes in patients with endometriosis: a pilot study. Biomedicines. 10:174. IF: 4.757. 2022. 
29. Hou YL, Li CJ, Lin LT, Chen SN, Wen ZH, Tsui KH. DHEA restores mitochondrial dynamics of cumulus cells by regulating PGAM5 expression in poor ovarian responders. Taiwan J Obstet Gynecol. 61:223. IF: 1.944. 2022.
30. Tsai HW, Li CJ, Lin LT, Chiang AJ, Chen SN, Wen ZH, Tsui KH. Expression status and prognostic significance of mitochondrial dynamics OPA3 in human ovarian cancer. Aging. 14:3874. IF: 5.955. 2022.
31. Tsai HW, Liao PF, Li CJ, Lin LT, Wen ZH, Tsui KH. High serum anti-Müllerian hormone concentrations have a negative impact on fertilization and embryo development rates. Reprod Biomed Online. 44: 171. IF: 4.567. 2022.
32. Tsai TE, Lin PH, Lian PF, Li CJ, Vitale SG, Mikuš M, Su WP, Tsai HW, Tsui KH, Lin LT. Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles. J Ovarian Res. 15:102. IF: 5.506. 2022.

2021

33. Li CJ, Lin LT, Tsai HW, Chern CU, Wen ZH, Wang PH, Tsui KH. The molecular regulation in the pathophysiology in ovarian aging. Aging Dis. 12:934. IF: 9.968. 2021. 
34. Chiu YH, Lin SC, Kuo CH, Li CJ*. Molecular machinery and pathophysiology of mitochondrial dynamics. Front. Cell Dev. Biol. 9:743892. IF: 6.081. 2021. 
35. Li CJ, Chiu YH, Chang C, Chang YC, Sheu JC, Chiang AJ. Acetyl coenzyme A synthase 2 acts as a prognostic biomarker associated with immune infiltration in cervical squamous cell carcinoma. Cancers. 13:3125. IF: 6.575. 2021. 
36. Li CJ, Lin LT, Tsui KH. Dehydroepiandrosterone shifts energy metabolism to increase mitochondrial biogenesis in female fertility with advancing age. Nutrients. 13:2449 . IF: 6.706. 2021. 
37. Li CJ, Tzeng YD, Chiu YH, Lin HY, Hou MF, Chu PY. Pathogenesis and potential therapeutic targets for triple negative breast cancer. Cancers. 13:2978.  IF: 6.575. 2021. 
38. Chu PY, Tzeng YD, Chiu YH, Lin HY, Kuo CH, Hou MF, Li CJ*. Multi-omics reveals the immunological role and prognostic potential of mitochondrial ubiquitin ligase MARCH5 in human breast cancer. Biomedicines. 9:1329. IF: 4.757. 2021. 
39. Li CJ, Lin LT, Chu PY, Chiang AJ, Tsai HW, Chiu YH, Huang MS, Wen ZH, Tsui KH. Identification of novel biomarkers and candidate drug in ovarian cancer. J. Pers. Med. 11:316. IF: 3.508. 2021.
40. Li CJ, Lin LT, Hou MF, Chu PY. PD-L1/PD-1 blockade in breast cancer: the immunotherapy Era. Oncol Rep. 45:5.  IF: 4.136. 2021.
41. Lin LT, Li CJ, Tsui KH. Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women. Sci Rep.  11:6336.  IF: 4.996. 2021.
42. Yang YL, Chang YH, Li CJ, Huang YH, Tsai MC, Chu PY, Lin HY. New insights into the role of miR-29a in hepatocellular carcinoma: implications in mechanisms and theragnostics. J. Pers. Med. 11:219. IF: 3.508. 2021.
43. Chiang AJ, Li CJ, Chang C, Chang YI, Cheng LW, Chang TH, Sheu JJ.  UBE2C drives human cervical cancer progression and is positively modulated by mTOR. Biomolecules. 11:37. IF: 6.064. 2021.
44. Chen YC, Li JY, Li CJ, Tsui KH, Wang PH, Wen ZH and Lin LT. Luteal phase ovarian stimulation versus follicular phase ovarian stimulation results in different human cumulus cell genes expression: A pilot study. Int. J. Med. Sci. 18: 1600. IF: 3.642. 2021.

2020

45. Li CJ, Tsui KH. Enhancement of human granulosa cells self-rescue by mitochondrial transfer via tunneling nanotubes. Fertil. Steril. 114:e350. IF: 7.490. 2020.
46. Tsui KH, Li CJ. CREB1 integrates the metabolic and growth networks associated with the aging of human granulosa cells. Fertil. Steril. 114:e426. IF: 7.490. 2020.
47. Tsui KH, Li CJ. Programmed mitophagy is essential for the glycolysis switching during senescence in human cumulus cells. Fertil. Steril. 114:e355. IF: 7.490. 2020.
48. Lin LT, Li CJ. High expression of PGAM family member 5 (PGAM5) is associated with diminished ovarian responder in cumulus cells. Fertil. Steril. 114:e224. IF: 7.490. 2020.
49. Lin LT, Li CJ. MitoQ shifts energy metabolism to increase biogenesis in human granulosa cells. Fertil. Steril. 114:e357. IF: 7.490. 2020.
50. Lin HY, Li CJ, Yang YL, Huang YH, Hsiau YT, Chu PY. Role of lysyl oxidase family members in tumor microenvironment and progression of liver cancer. Int J Mol Sci. 21:9751. IF: 6.208. 2020.
51. Li CJ. Oxidative stress and mitochondrial dysfunction in human diseases: pathophysiology, predictive biomarkers, therapeutic. Biomolecules. 10:1558. IF: 6.064. 2020.
52. Li CJ, Lin HY, Ko CJ, Lai JC, Chu PY. A novel biomarker driving poor-prognosis liver cancer: overexpression of the mitochondrial calcium gatekeepers. Biomedicines. 8:E451. IF: 4.757. 2020.
53. Li CJ, Chen HM, Lai JC. Diagnostic, prognostic, and predictive biomarkers in breast cancer.  J Oncol. 2020:1835691. IF: 4.501. 2020.
54. Wu MY, Lai TT, Liao WT, Li CJ*. Clinicopathological and prognostic significance and molecular mechanism in uveal melanoma. Ther Adv Med Oncol. 12:1. IF: 5.485. 2020.
55. Peng NJ, C Hu, Chiu YL, Yu CC, Li CJ, Sheu JJ, Chiang AJ. Detection of recurrent cervical cancer and prediction of its patient survival with serum squamous-cell carcinoma-antigen and 2-[18 F] fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography. Diagnostics. 10:657. IF: 3.992. 2020.
56. Lin PS, Lin LT, Li CJ, Kao PG, Tsai HW, Chen SN, Wen ZH, Wang PH, Tusi KH. Combining bioinformatics and experiments to identify CREB1 as a key regulator in senescent granulosa cells. Diagnostics. 10:295. IF: 3.992. 2020.
57. Tsai HW, Wang PH, Hsu PT, Chen SN, Lin LT, Li CJ, Tsui KH.  Laser irradiation pretreatment improves endometrial preparation of frozen-thawed embryo transfer in recurrent implantation failure patients. Gynecol Endocrinol. 13:1-5. IF: 2.277. 2020.
58. Li JY, Li CJ, Lin LT, Tsui KH. Multi-omics analysis identifying key biomarkers in ovarian cancer. Cancer Control. 27:1073274820976671. IF: 2.339. 2020.

2019

59. Tsui KH, Wu MY, Lin LT, Wen ZH, Li YH, Chu PY, Li CJ*. Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms. Theranostics. 9:6631. IF: 11.600. (Cover story). 2019.
60. Li CJ, Chu PY, Yiang GT, Wu MY. The molecular mechanism of epithelial-mesenchymal transition for breast carcinogenesis. Biomolecules. 9:E476. IF: 6.064. 2019.
61. Wang CN, Li CY, Cai JH, Sheu CY, Tsai JP, Wu MY, Li CJ*, Hou MF*. Identification of prognostic candidate genes in breast cancer by integrated bioinformatic Analysis. J Clin Med. 8:1160. IF: 4.964. 2019.
62. Liao WT, Su CC, Lee MT, Li CJ, Lin CL, Chiang JH, Yen HR. Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study. J Ethnopharmacol. 243:112091. IF: 5.195. 2019.
63. Ko CJ, Li CJ, Wu MY, Chu PY. Overexpression of LGR-5 as a predictor of poor outcome in patients with hepatocellular carcinoma. J Environ Res Public Health. 16:1836. IF: 4.614. 2019.
64. Chen SN, Chang R, Lin LT, Chern CU, Tsai HW, Wen ZH, Li YH, Li CJ, Tsui KH. MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities. Int J Environ Res Public Health. 16:1510. IF: 4.614. 2019.
65. Li CJ, Chen CS, Yiang GT, Tsai PY, Liao WT, Wu MY. Advanced evolution of pathogenesis concepts in cardiomyopathies. J Clin Med. 8:520. IF: 4.964. (Cover story). 2019.
66. Chiu HC, Li CJ, Yiang GT, Tsai PY, Wu MY. EMT and cell biology of molecular regulation in endometrial carcinogenesis. J Clin Med. 8:439. IF: 4.964. 2019.

2018

67. Li CJ, Chen SN, Lin LT, Chern CU, Wang PH, Wen ZH, Tsui KH. DHEA modulates abnormal mitochondrial dynamics and mitophagy of cumulus Cells in poor ovarian responders. J Clin Med. 7:293. IF: 4.964. 2018.
68. Lin YT, Wu YC, Sun GC, Ho CY, Wong TY, Lin CH, Chen HH, Yeh TC, Li CJ, Tseng CJ, Cheng PW. Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer’s disease. J Clin Med. 7:329. IF: 4.964. 2018.
69. Wu MY, Yiang GT, Chen YL, Li CJ*, Lin SC*. Clinical outcome and management for geriatric traumatic injury: analysis of 2688 cases in emergency department at a teaching hospital in Taiwan. J Clin Med. 7:255. IF: 4.964. 2018.
70. Wang SC, Wang SC, Li CJ, Lin CH, Huang HL, Tsai LM, Chang CH. The therapeutic effects of traditional Chinese medicine for poor semen quality in infertile males. J Clin Med. 7:239. IF: 4.964. 2018.
71. Wu MY, Chen CS, Yiang GT, Cheng PW, Chiu HC, Liu KH, Lee WC, Li CJ*. The molecular regulation in the pathogenesis of IgA nephropathy. J Clin Med. 7:225. IF: 4.964. 2018.
72. Wu MY, Yiang GT, Lai TT, Li CJ*. The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med and Cell Longev. 2018:3420187. IF: 7.310. 2018.
73. Wu MY, Yiang GT, Cheng PW, Chu PY, Li CJ*. Molecular targets in hepatocarcinogenesis and implications for therapy. J Clin Med. 7, 213. IF: 4.964. (Cover story). 2018.
74. Chiu HC, Wu MY, Li CH, Huang SC, Yiang GT, Yen HS, Liu WL, Li CJ*, Kao WY*. EMT with malignant transformation leading multiple metastasis from leiomyomatosis peritonealis disseminata. J Clin Med. 7:207. IF: 4.964. 2018.
75. Ko CJ, Li CJ, Wu MY, Chu PY. Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma. Exp Ther Med. 16:4810. IF: 2.751. 2018.
76. Liao WT, Chiang JH, Li CJ, Lee MT, Su CC, Yen HR. Investigation on the use of traditional Chinese medicine for polycystic ovary syndrome in a nationwide prescription database in Taiwan. J Clin Med. 7:179. IF: 4.964. 2018.
77. Wu MY, Lee LC, Chen YL, Yeh YH, Li CJ*, Yiang GT*. Septic pulmonary emboli or pulmonary metastasis in a patient with diabetes mellitus? J Clin Med. 7:176. IF: 4.964. 2018.
78. Yang CY, Chen CS, Yiang GT, Cheng YL, Yong SB, Wu MY, Li CJ*. New insights into the immune molecular regulation of the pathogenesis of acute respiratory distress syndrome. Int J Mol Sci. 19:588. IF: 6.208. 2018.
79. Wu MY, Yiang GT, Liao WT, Tsai PY, Cheng PW, Li CY, Li CJ*. Current concepts of the mechanism in ischemia and reperfusion injury. Cell Physiol Biochem. 46:1650. IF: 5.5. 2018.
80. Wu MY^#, Li CJ^#, Yiang GT, Hou YT, Hou MF, Chu PY. # co-first. Molecular regulation of bone metastasis pathogenesis. Cell Physiol Biochem. 46:1423. IF: 5.5. 2018.
81. Lin SC, Chu PY, Liao WT, Wu MY, Tsui KH, Chen LL, Li CJ*. Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway. Oncol Rep. 39:703. IF: 4.136. 2018.

2017

82. Wu MY, Li CJ, MF Hou, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 18:2034. IF: 6.208. 2017.
83. Li CJ, Liao WT, Wu MY, Chu PY. New insights into the role of autophagy in tumor immune microenvironment. Int J Mol Sci. 18:1566. IF: 6.208. 2017.
84. Lin LT, Chen JT, Chao KC, Li CJ, Tsui KH. Dehydroepiandrosterone as a potential agent to slow down ovarian aging. J Obstet Gynaecol Res. 43: 1855. IF: 1.697. 2017.
85. Li CJ, Chen PK, LY Sun, Pang CY. Enhancement of mitochondrial transfer by antioxidants in human mesenchymal stem cells. Oxid Med and Cell Longev. 2017:851085. IF: 7.310. 2017.
86. Lin LT, Wang PH, Wen ZH, Li CJ, Chen SN, Tsai EM, Cheng JT, Tsui KH. The application of DHEA on improving mitochondrial function and reducing apoptosis of cumulus cells in poor ovarian responders. Int J Med Sci. 14: 585. IF: 3.642. 2017.
87. Tsui KH, Wang PH, Lin LT, Li CJ. DHEA protect mitochondria against dual modes of apoptosis and necroptosis in granulosa cells. Reproduction. 154:101. IF: 3.923. 2017.

2016-2009

88. Lin LT, Wang PH, Chen SN, Li CJ, Wen ZH, Cheng JT, Tsui KH. Protection of cumulus cells following DHEA supplementation. Gynecol Endocrinol. 33: 100. IF: 1.585. 2016.
89. Li CJ, LY Sun, Pang CY. Synergistic protection of N-acetylcysteine and ascorbic acid 2-phosphate on human mesenchymal stem cells against mitoptosis, necroptosis and apoptosis. Sci Rep. 5: 9819. IF: 4.996. 2015.
90. Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF, Yeh JI, Hsu HY. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 319: 203. IF: 9.756. 2012.
91. Li CJ, Tsang SF, Tsai CH, Tsai HY, Chyuan JH, Hsu HY. Momordica charantia-induced extract induces apoptosis in human cancer cells through caspase-dependent and mitochondria-dependent pathway. Evid Based Complement Alternat Med. 2012: 261971. IF: 2.650. 2012.
92. Li CJ, Huang SY, Wu MY, Chen YC, Tsang SF, Chyuan JH, Hsu HY. Induction of apoptosis by ethanolic extract of Corchorus olitorius leaf in human hepatocellular carcinoma (HepG2) cells via a mitochondria dependent pathway. Molecules. 17: 9348. IF: 4.4927. 2012.
93. Tseng HL, Li CJ, Chen CY, Huang LH, Lin CN, Hsu HY. Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway. Toxicol Appl Pharmacol. 264: 104. IF: 4.460. 2012.
94. Hsu HY, Lin JH, Li CJ, Tsang SF, Tsai CH, Chyuan JH, Chiu SJ, Chuang SE. Anti-migratory effects of the methanol-extract from Momordica charantia on human lung adenocarcinoma CL1 cells. Evid Based Complement Alternat Med. 2012: 819632. IF: 2.630. 2012.
95. Huang WT, Li CJ, Wu PJ, Chang YS, Lee TL, Weng CF. Expression and in vitro regulation of pituitary adenylate cyclase-activating polypeptide (PACAP38) and its type I receptor (PAC1-R) in the gonads of tilapia (Oreochromis mossambicus). Reproduction. 137: 449. IF: 3.923. 2009.